BPA

Ovarian and Prostate Cancer Virtual Education Series

The European Society of Pathology (ESP) would like to invite you to take part in the online survey (LINK) which aims at evaluating the learning objectives and content of the ESP virtual preceptorships which were developed in collaboration with AZ and MSD for diagnostic testing in prostate and ovarian cancers. To access the virtual preceptorship platform please visit the ESP website.Your feedback is vital for improving the objective and content of the forthcoming ESP educational programmes. We would like to take this opportunity…

Пълният текст

To Whom It May Concern

Dear Bulgarian Colleagues!* My name is Olena Dyadyk, I am as a member of the ESP,  Advisor board from Ukraine of ESP, current member of the International Academy of Pathology; coordinator of cooperation between Ukraine and the Royal College of Pathologists of Great Britain; member of the Ukrainian Association of Child Nephrology (UADN) and the European Society for Pediatric Nephrology (ESPN); member of the Ukrainian Club of Pancreatologists and the European Pancreatic Club (EPC). I am the full Professor, MD, Dr. Sci., Head…

Пълният текст

Intracellular Reverse Transcription of Pfizer BioNTech COVID-19 mRNA Vaccine BNT162b2 In Vitro in Human Liver Cell Line

by Markus Aldén 1,Francisko Olofsson Falla 1,Daowei Yang 1,Mohammad Barghouth 1,Cheng Luan 1,Magnus Rasmussen 2 andYang De Marinis 1,* Department of Clinical Sciences, Lund University, 20502 Malmö, Sweden2Infection Medicine, Department of Clinical Sciences, Lund University, 22362 Lund, Sweden*Author to whom correspondence should be addressed.Academic Editor: Stephen MalnickCurr. Issues Mol. Biol.2022, 44(3), 1115-1126; https://doi.org/10.3390/cimb44030073Received: 18 January 2022 / Revised: 19 February 2022 / Accepted: 23 February 2022 / Published: 25 February 2022 Abstract Preclinical studies of COVID-19 mRNA vaccine BNT162b2, developed by Pfizer and BioNTech, showed reversible hepatic effects in animals that received the BNT162b2 injection. Furthermore, a…

Пълният текст

ESP 2022 EQA Schemes

Invitation for participation The European Society of Pathology (ESP) Foundation is continuing the successful organisation of External Quality Assurance (EQA) Programmes.  For 2022 we are proud to announce three separate EQA Schemes:  – The Colorectal Carcinomas (CRC) EQA Scheme includes KRAS, NRAS and BRAF testing. For more information please see the attaced CRC flyer. Registrations are open until 1 February 2022 and are available HERE. – The Programmed Death Ligand 1 (PDL1) EQA Scheme includes testing in triple negative breast carcinoma (TNBC), non-small cell lung carcinoma (NSCLC), urothelial…

Пълният текст

EUROPEAN SOCIETY OF PATHOLOGY ACADEMY (ESPA)

The European Society of Pathology (ESP) is proud to announce the second edition of ESP Academy (ESPA), devoted to the promotion of applied and translational scientific research in the field of human pathology.  The ESPA 2022 is scheduled for 18-21 June 2022, in Genval, Belgium.ESPA is an intensive, interactive four-day workshop designed to support early career pathologists and scientists. Admission to the ESPA is by competitive application based on the candidate’s curriculum vitae, clinical and research experience, and significance of the proposed…

Пълният текст

ECP 2022 Basel

After two virtual ECPs in a row, ESP is excited to go live again! And Basel, Switzerland is the city which will see the revival – the 34th European Congress of Pathology will take place from 3 to 7 September 2022 at the Congress Center Basel.  The motto for the ECP 2022 – The Art of Next Generation Pathology – encompasses the broad range of modern pathology, including next generation technologies as well as the next generation of pathologists but also points to the intuition and…

Пълният текст

Seasonal greetings

The European Society of Pathology (ESP) would like to wish you and your Family a peaceful and joyful festive season and a healthy & happy New Year. Please accept our thanks for your continued support to the ESP, which is particularly appreciated during these challenging times. Our offices will close on Friday, 24 December 2021 and reopen on Tuesday, 4 January 2022. Sincerely,European Society of Pathology

Пълният текст

ESDIP Newsletter – Winter 2021 Edition

ESDIP Newsletter – Winter 2021 edition A word from the Presidentby Catarina EloyDear Members of ESDIP, Almost two years have passed by since the COVID-19 pandemic started to dominate the news. Now, the hope on renovation of the social activities is expressed by new and old style live events on the agenda. At ESDIP, we are also living these moments with joy and hope. The cruise is navigating at good and stable speed, valuable members keep joining the active structure, contributing to renovation…

Пълният текст

ESP Pathology Progress Test 2021 – Reminder

The European Society of Pathology (ESP) in close collaboration with the UEMS Board of Pathology announces the 2021 Pathology Progress Test (PPT).  From 24th of November until 10th of December 2021 those interested are invited to take the PPT, which is primarily intended for trainees, but any pathologist curious to submit her or his knowledge base to the test is welcome to participate. The test consists of 120 questions, in a multiple-choice question (MCQ) format. The questions are partly only text, partly still…

Пълният текст